PPAR agonists for primary biliary cholangitis
Lancet Gastroenterol Hepatol
.
2017 Oct;2(10):693-694.
doi: 10.1016/S2468-1253(17)30256-X.
Epub 2017 Aug 14.
Authors
Andrea A Gossard
1
,
Gregory J Gores
2
Affiliations
1
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
2
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: gores.gregory@mayo.edu.
PMID:
28818517
DOI:
10.1016/S2468-1253(17)30256-X
No abstract available
Publication types
Comment
MeSH terms
Cholangitis
Humans
Immunosuppressive Agents
Liver Cirrhosis, Biliary*
Peroxisome Proliferator-Activated Receptors*
Substances
Immunosuppressive Agents
Peroxisome Proliferator-Activated Receptors